Clinical Trials Directory

Trials / Completed

CompletedNCT05330754

Caffeine Intake Inrelation to Perioperative Analgesic Consumption

Effect Of Daily Caffeine Intake On Perioperative Analgesic Consumption And Recovery Time In Patients Undergoing Laparoscopic Surgeries.

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Caffeine is the most widely consumed psychoactive drug in the world. Natural sources of caffeine include coffee, tea, and chocolate. Synthetic caffeine is also added to products to promote arousal, alertness, energy, and elevated mood. We designed this prospective observational study to determine if caffeine consumption would influence intraoperative analgesic consumption

Detailed description

Caffeine is a well-known natural compound present in various plant products. Caffeine is an integral component of several daily drinks, including tea, coffee, soft drinks, and energy drinks \[1\]. (e consumption habits of these caffeinated drinks have facilitated the wide distribution of and dependence on caffeine. For instance, 89% of the US adult population has an average caffeine intake of 200 mg/day \[2\]. Among the multiple effects and side effects, caffeine also has an analgesic action and is used to reduce pain in several pharmaceutical forms as an adjuvant \[1\]. Several studies have reported a role for caffeine in controlling pain and suggested that caffeine may block the central processing of pain signals in the brain and enhance the body's natural pain resistance pathways \[3\]. In addition, Overstreet et al. found that habitual caffeine consumption diminishes pain sensitivity in a laboratory setting \[4\]

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeine intake in mgPreanesthetic check-up was done. Average daily caffeine consumption in mg was calculated according to "caffeine content in consumed drinks" as estimated by "Food Data Central".

Timeline

Start date
2022-04-20
Primary completion
2022-08-30
Completion
2022-09-10
First posted
2022-04-15
Last updated
2022-11-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05330754. Inclusion in this directory is not an endorsement.